Physician profile
Basem A Abdelfattah
NPI 1467688853
$15,246.32
in general payments reported to CMS, 2019-2025
38 companies · $868 in 2025
The $868 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,394 · 2020: $2,220 · 2021: $4,256 · 2022: $2,927 · 2023: $757 · 2024: $1,824 · 2025: $868.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,449.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,596.53 | 2019-2025 | Eterna, Proclaim, Octrode |
| Medtronic, INC. | $2,551.67 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Biohaven Pharmaceutical Holding Company LTD. | $1,707.82 | 2022 | |
| Spinal Simplicity, LLC | $1,600.95 | 2021-2025 | Ha Minuteman G3-R |
| Medtronic USA, INC. | $1,445.55 | 2019-2020 | |
| Nevro Corp. | $1,055.66 | 2019-2024 | Senza |
| Si-Bone, INC. | $521.24 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $502.20 | 2019-2025 | Ztlido |
| Edwards Lifesciences Corporation | $400.00 | 2021 | |
| Collegium Pharmaceutical, INC. | $327.95 | 2019-2025 | Belbuca, Xtampza |
| Abbvie INC. | $325.50 | 2021-2025 | Ubrelvy, Qulipta |
| Vertiflex, INC. | $255.65 | 2019 | |
| Arbor Pharmaceuticals, INC. | $199.00 | 2019-2022 | |
| Boston Scientific Corporation | $185.09 | 2020-2025 | Wavewriter Alpha Prime 16 |
| Azurity Pharmaceuticals, INC. | $182.94 | 2023-2025 | Horizant, Horizant |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $162.54 | 2021 | |
| Amgen INC. | $152.55 | 2020-2023 | Aimovig |
| Vgi Medical, LLC | $150.27 | 2022 | |
| Pfizer INC. | $148.08 | 2019-2025 | |
| Heron Therapeutics, INC. | $80.52 | 2022 | |
| Almatica Pharma LLC | $79.17 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $67.62 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $60.09 | 2020-2021 | |
| Globus Medical, INC. | $54.57 | 2025 | Senza |
| Novartis Pharmaceuticals Corporation | $50.04 | 2020-2021 | |
| Tersera Therapeutics LLC | $46.40 | 2019 | |
| Allergan, INC. | $41.94 | 2020 | |
| Horizon Therapeutics Plc | $37.58 | 2019-2021 | |
| Assertio Therapeutics, INC. | $35.49 | 2019 | |
| Forte Bio-Pharma LLC | $32.80 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $32.14 | 2025 | |
| Spr Therapeutics, INC | $31.11 | 2024-2025 | Sprint Pns System |
| Ibsa Pharma INC. | $28.43 | 2021 | |
| Biodelivery Sciences International, INC. | $24.51 | 2019-2020 | |
| Vertos Medical, INC. | $22.56 | 2021 | |
| Avanos Medical | $19.68 | 2025 | Generator |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.65 | 2022 | |
| Lilly USA, LLC | $12.83 | 2023 | Emgality |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basem Abdelfattah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.